Navigation Links
Tanke BioSciences To Host Leading Symposium On Food Safety, June 24-25
Date:6/22/2012

NEW YORK, June 22, 2012 /PRNewswire/ -- Tanke BioSciences Corporation (OTCQB: TNBI), a China-based integrated biotech company that develops, manufactures, and markets animal feed additives and livestock nutritional products, today announced it will be sponsoring the Fifth Biannual International Symposium on Feed Additive, Animal Nutrition & Health, June 24 and 25, at the Dragon Lake Princess Hotel in Guangzhou, China.              

The Symposium, organized by the Chinese Academy of Agricultural Sciences, will feature many of the world's top researchers in animal nutrition who will make presentations on the latest advances in animal feed additives and animal food safety.  These speakers and panelists will be from the Chinese Academy of Sciences, the Chinese Ministry of Agriculture, the Chinese Academy of Engineering, as well as from leading universities in China, the U.S. and New Zealand. 

Among the speakers will be Dr. Paul J. Moughan, Distinguished Professor at Massey University, New Zealand and Fellow of the British Royal Society of Chemistry, and Dr. Xingen Lei, Professor of Molecular Nutrition at Cornell University in Ithaca, New York. Dr. Moughan is widely regarded as a world authority on mammalian protein metabolism and food evaluation science and has published some 350 works of scholarship.  Dr. Lei, a recipient of the prestigious Mead Johnson Award from the American Society of Nutritional Sciences, is generally considered to be among the foremost experts in animal food nutrition and safety.

Also making presentations will be Tanke's chief engineer, Professor Bing Teng, and the company's director of marketing, Dr. Zhiying Cui.  These presentations will discuss a number of new animal feed additives including organic trace mineral additives, a rapidly growing product category that offers many safety, cost and environmental advantages over conventional inorganic mineral additives.

Tanke is the largest producer of organic trace minerals in China. The company is scheduled to open its second plant in China for producing these minerals by spring 2013. This plant is expected to help Tanke significantly increase its organic trace minerals market share.  These minerals, as well as Tanke's other products, are free of antibiotics and genetically modified organisms (GMOs).

Attendees to the Tanke Symposium will include CEOs, general managers, and chief technology officers of mid- to large-size animal feed producers, university professors and researchers, as well as national and local government officials.

"We are very proud to be sponsoring this conference," said Tanke founder and CEO, Guixiong Qiu. "With the myriad of challenges facing China in the area of food safety, we believe our Symposium will disseminate the latest and most vital information about the newest technologies available to ensure that the Chinese people, and other peoples around the world, receive safe, nutritious and affordable food."

Dr. Lei added, "I am delighted to speak at this conference and encouraged to see the scientific and technological progress in China's animal feed additive industry, especially the increased utilization of organic trace minerals to enhance animal health, food safety, and environmental protection."        

About Tanke BioSciences Corporation

Founded in 1997, Tanke BioSciences Corp. (http://tanke-bio.com/) is based in Guangdong Province and competes in China's $6 billion animal feed additive market. The company's products directly address China's soaring demand for safe, reasonably priced food.

Forward-Looking Statements

This press release and the statements of representatives of our officers, directors, employees and representatives related thereto contain or may contain forward-looking statements which are based upon the current beliefs and expectations of our management. Such statements contained in this release are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "guidance," "projects," "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "ultimately" and words of similar import, are intended to identify any forward-looking statements. The information contained in the forward looking statements is inherently uncertain, and our actual results may differ materially due to a number of factors, many of which are beyond our ability to predict or control, including, among others: (i) changes in the level of consumer spending or preferences or demand for our products; (ii) pressures from competition; (iii) our ability to hire and retain key personnel and our relationship with our employees; (iv) the performance of our distributors and other key vendors; (v) effectively carrying out and managing our growth strategies; (vi) failure to maintain the value and image of our brand and protect our intellectual property rights; (vii) seasonality; (viii) costs of materials and labor; (ix) sales, manufacturing, supply or distribution difficulties or disruptions; (x) compliance with or changes in Chinese, U.S. or international laws and regulations; (xi) costs as a result of operating as a public company; (xii) material weaknesses in internal controls; (xiii) interest rate and foreign currency risks; (xiv) our ability to maintain our land use and drug manufacturing rights in China; (xv) general economic and industry conditions in China and internationally, and other risks as more fully detailed in our filings with the Securities and Exchange Commission ("SEC"). Our filings with the SEC are available at www.sec.gov. You are urged to consider these factors carefully in evaluating our forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements which are qualified in their entirety by this cautionary statement. The forward-looking statements speak only as of the date on which they are made, and the company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances unless as required by applicable laws or regulations.

Investor Contact:

Jimmy Caplan
Market Makers
(512) 329-9505

Media Contact:

Rick Eisenberg
Eisenberg Communications                                                                                                         (917) 691-8934

 


'/>"/>
SOURCE Tanke BioSciences Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Amarantus BioSciences Featured in BioWorld Today, Brewer Sports Symposium and Opportunist Magazine
2. Entia Biosciences Receives Patent for Use of Ergothioneine in Foods and Beverages
3. IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
4. Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences
5. Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates
6. Sangamo BioSciences Reports First Quarter 2012 Financial Results
7. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
8. Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
9. Covington Advises AstraZeneca in $1.26 Billion Acquisition of Ardea Biosciences
10. IntelliCell BioSciences Expands Management Team
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per share will be ... record as of the close of business on June 24, ... the Board of Directors and may be adjusted as business ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... focused on molecular nanotechnology, announced the winners for the 2015 Foresight Institute Feynman ... Feynman, are given in two categories, one for experiment and the other for ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
(Date:5/19/2016)... There is no saying when ... relentless pressures in pricing and lack in consumer confidence. ... though - numerous opportunities are up for grabs but ... presents four names in this sector: Portola Pharmaceuticals Inc. ... VTAE ), Anthera Pharmaceuticals Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:3/15/2016)... March 15, 2016 --> ... by Transparency Market Research "Digital Door Lock Systems Market - ... - 2023," the global digital door lock systems market in ... 2014 and is forecast to grow at a CAGR of ... small and medium enterprises (MSMEs) across the world and high ...
(Date:3/11/2016)... http://www.apimages.com ) - --> http://www.apimages.com ) - ... ( http://www.apimages.com ) - Germany . The ... refugee identity cards. DERMALOG will be unveiling this device, and a ... next week.   --> Germany . ... new refugee identity cards. DERMALOG will be unveiling this device, and ...
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
Breaking Biology News(10 mins):